经硬膜内动脉中间导管注射对比剂与神经介入术后对比剂脑病相关
该回顾性研究纳入2012年2月至2023年1月期间396例接受脑动脉瘤神经介入治疗的420个动脉瘤,14例(3.5%)发生对比剂脑病。多因素logistic回归显示,经硬膜内动脉置管造影(OR=40.4;95%CI 8.63-189)和既往治疗过的动脉瘤(OR=8.20;95%CI 2.26-29.6)是对比剂脑病的独立预测因素。作者认为经硬膜内动脉注射对比剂和复发动脉瘤再治疗是主要风险因素,应注意中间导管造影时的位置以避免对比剂脑病。
要点
- 经硬膜内动脉置管造影是对比剂脑病的强独立预测因素(OR=40.4;95%CI 8.63-189)。
- 既往治疗过的动脉瘤再治疗也是独立预测因素(OR=8.20;95%CI 2.26-29.6)。
- 396例中14例(3.5%)发生对比剂脑病,提示需关注中间导管位置。
核心结论
- 经硬膜内动脉注射对比剂和复发动脉瘤再治疗是对比剂脑病的主要风险因素,应注意中间导管造影时的位置以避免对比剂脑病。
研究设计与样本
- 回顾性研究,纳入2012年2月至2023年1月在本机构接受颅外动脉瘤和未破裂颅内动脉瘤神经介入治疗的396例患者共420个连续动脉瘤,分为对比剂脑病组和无对比剂脑病组,采用多因素logistic回归分析和逐步选择比较临床、解剖和手术因素。
诊断标准与关键数值
- 对比剂脑病组与无对比剂脑病组比较,单因素分析显示血液透析患者比例、既往治疗动脉瘤比例、硬膜内动脉置管造影比例、非离子型对比剂比例和血流导向装置手术比例均显著更高。
- 逐步多因素logistic回归分析显示硬膜内动脉置管造影(OR=40.4;95%CI 8.63-189)和既往治疗动脉瘤(OR=8.20;95%CI 2.26-29.6)是对比剂脑病的独立预测因素。
临床应用与阅片要点
- 作者建议注意中间导管用于造影时的位置,以避免发生对比剂脑病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Contrast-induced encephalopathy can result from neurotoxicity of contrast medium in the affected area. The development of intermediate catheters has allowed guidance of catheters to more distal arteries. This study focused on the association between contrast-induced encephalopathy and contrast injection from an intermediate catheter guided into a distal intradural artery during neurointervention for cerebral aneurysms.
MATERIALS AND METHODS: We retrospectively reviewed 420 consecutive aneurysms in 396 patients who underwent neurointervention for extracranial aneurysms and unruptured intracranial aneurysms at our institution from February 2012 to January 2023. Patients were divided into a group with contrast-induced encephalopathy and a group without. To identify risk factors for contrast-induced encephalopathy, we compared clinical, anatomic, and procedural factors between groups by multivariate logistic regression analysis and stepwise selection.
RESULTS: Among the 396 patients who underwent neurointervention for cerebral aneurysms, 14 (3.5%) developed contrast-induced encephalopathy. Compared with the group without contrast-induced encephalopathy, the group with contrast-induced encephalopathy showed significantly higher rates of patients on hemodialysis, previously treated aneurysms, intradural placement of a catheter for angiography, nonionic contrast medium, and flow-diversion procedures in univariate analyses. Stepwise multivariate logistic regression analysis revealed intradural placement of a catheter for angiography (OR = 40.4; 95% CI, 8.63-189) and previously treated aneurysms (OR = 8.20; 95% CI, 2.26-29.6) as independent predictors of contrast-induced encephalopathy.
CONCLUSIONS: Contrast injection from an intradural artery and retreatment of recurrent aneurysms were major risk factors for contrast-induced encephalopathy. Attention should be paid to the location of the intermediate catheter for angiography to avoid developing contrast-induced encephalopathy.
引用
- Fuga M, Tanaka T, Tachi R, et al. Contrast Injection from an Intermediate Catheter Placed in an Intradural Artery is Associated with Contrast-Induced Encephalopathy following Neurointervention. AJNR Am J Neuroradiol. 2023. PMID: 37536732. doi:10.3174/ajnr.A7944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。